Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walter Morton who wrote (1427)	9/20/1998 3:50:00 PM
From: Rudy Saucillo	Read Replies (3) of 2742

Walter, I'd be very surprised if Pasteur Merieux Connaught decided to buy Cistron. They simply want access to CIST's adjuvant technology as they have similar access to vaccine technology from other companies. I do hope Cistron is in serious negotiations to sell the company. The selling price will certainly be a function of the strength of the Pasteur Merieux Connaught agreement - details which should be announced any day now. I would think that 75 cents/share for CIST shareholders would be a minimum if the company is sold. If CIST negotiated well with PMC and we get a strong press release providing some details, we should start moving in this direction. Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next